The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM, Completion of Placing, TVRs

12 Sep 2016 11:53

RNS Number : 5784J
Microsaic Systems plc
12 September 2016
 

Microsaic Systems plc

 

("Microsaic", "Microsaic Systems" or the "Company")

 

Result of General Meeting, Completion of Placing and Total Voting Rights

 

 

12 September 2016

 

On 26 August 2016, Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announced a proposed Placing to raise up to £5.4 million (before expenses) through the issue of up to 108,000,000 new ordinary shares of 0.25p each ("New Ordinary Shares") at an issue price of 5 pence per New Ordinary Share.

 

The Company is pleased to announce that, at its General Meeting held earlier today, the Resolution put to shareholders to authorise the directors of the Company to allot the New Ordinary Shares in connection with the proposed Placing was duly passed.

 

Further to this, the Company can now confirm that it will issue, pursuant to the Placing, 108,000,000 New Ordinary Shares at 5 pence per share, raising £5.4 million (before expenses). Application has been made for the 108,000,000 New Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will become effective and trading will commence in the New Ordinary Shares at 8.00 a.m. on 13 September 2016. Following Admission the Company's issued share capital will comprise 181,365,146 Ordinary Shares. From Admission, the figure of 181,365,146 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Colin Nicholl, Chairman of Microsaic, said:

''We are grateful to our existing shareholders as well as new investors for supporting this issue. The funds raised will provide the Company with the resources to develop our existing partnerships, secure additional relationships, and to increase the spread of applications that are addressed. This in turn will allow the business to grow in a profitable way."

 

Defined terms used in this announcement will have the meanings (unless the context otherwise requires) set out in the circular dated 26 August 2016, which is available on the Company's website at http://www.microsaic.com.

 

 

Enquiries:

Microsaic Systems plc

Jim Ramage, CEO

Bevan Metcalf, FD

+44 (0) 1483 751577

 

N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson

Liz Yong

 

 

+44 (0)20 7496 3000

Citigate Dewe Rogerson (Financial PR)

Mark Swallow, Marine Perrier

+44 (0)20 7282 2948/1068

About Microsaic Systems

 

Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.

 

Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.

 

The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.

 

The Microsaic 4000 MiD®, single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).

 

www.microsaic.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUGABUPQGUP
Date   Source Headline
30th May 20141:09 pmRNSNotification of Major Interest in Shares
6th May 201411:58 amRNSGRANT OF SHARE OPTIONS
30th Apr 20147:00 amRNSPreliminary Results
28th Apr 201412:33 pmRNSNotification of Major Interest in Shares
23rd Apr 20148:18 amRNSNotification of Major Interest in Shares
17th Apr 20149:19 amRNSHolding(s) in Company
15th Apr 20149:17 amRNSAppointment of Finance Director
14th Apr 20149:42 amRNSRe Agreement
11th Dec 20133:56 pmRNSHolding(s) in Company
21st Oct 20137:00 amRNSFormation of new Scientific Advisory Group
27th Sep 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSAppointment of Chairman
24th Jun 20137:00 amRNSIssue of Equity
4th Jun 20135:08 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSMicrosaic welcomes launch of the IsoleraT Dalton
31st May 201310:28 amRNSHolding(s) in Company
28th May 20132:44 pmRNSHolding(s) in Company
24th May 201311:23 amRNSResults of General Meeting
15th May 201311:23 amRNSResults of Annual General Meeting
7th May 20134:35 pmRNSDistribution of Circular of General Meeting
3rd May 20136:25 pmRNSConditional Placing to Raise up to £4.28 million
22nd Apr 20137:00 amRNSDistribution of Annual Report and Accounts
15th Apr 20137:00 amRNSPreliminary Results
10th Apr 20137:00 amRNSSigning of commercial agreement
15th Mar 20131:05 pmRNSHolding(s) in Company
14th Mar 20139:00 amRNSLaunch New Chip-based Mass Spectrometry Instrument
12th Dec 20129:36 amRNSGrant of Share Options
19th Oct 20124:45 pmRNSDirector/PDMR Shareholding
15th Oct 20122:26 pmRNSDirector/PDMR Shareholding
24th Sep 20127:00 amRNSAppointment of new CEO
24th Sep 20127:00 amRNSInterim Results
4th Sep 201210:00 amRNSAgreement
4th Jul 20129:46 amRNSGrant of Share Options
25th Jun 201210:29 amRNSMicrosaic Wins R&D100 Award
8th Jun 201210:53 amRNSHolding(s) in Company
7th Jun 20127:00 amRNSHolding(s) in Company
30th May 20123:40 pmRNSHolding(s) in Company
30th May 201211:36 amRNSAGM Results
29th May 201210:35 amRNSHolding(s) in Company
29th May 20127:00 amRNSPlacing
11th May 20129:18 amRNSHolding(s) in Company
9th May 20127:00 amRNSRe Agreement
30th Apr 20122:22 pmRNSDistribution of Annual Report and Accounts
25th Apr 20127:00 amRNSPreliminary Results
18th Apr 201210:07 amRNSMicrosaic Exhibits at Analytica 2012
22nd Feb 201211:21 amRNSHolding(s) in Company
12th Dec 20117:00 amRNSDirectorate Change
25th Nov 20119:04 amRNSExercise of Share Options
2nd Nov 20118:59 amRNSHolding(s) in Company
5th Oct 20119:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.